GM2-gangliosidosis, AB variant: clinico-pathological study of a case
- PMID: 174379
- DOI: 10.1007/BF00688395
GM2-gangliosidosis, AB variant: clinico-pathological study of a case
Abstract
Clinical and neuropathological studies of a case of AB variant GM2-gangliosidosis have been presented. The patient was a 14 months old black female infant who had "black cherry spot" in the retinas. The total activities of beta-galactosidase and N-acetyl-beta-hexosaminidase, as well as the proportion of hexosaminidase A and B components in her serum and leukocytes were normal when the assays were carried out with artificial fluorogenic substrate. Diagnosis of GM2-gangliosidosis AB variant was established by an abnormal increase of GM2-ganglioside in the biopsied brain tissue, similar to classical Tay-Sachs disease. Her clinical manifestation appeared to be similar but somewhat milder than those of classical Tay-Sachs disease. Light microscopic features of the cerebral biopsy were also closely similar to Tay-Sachs disease and Sandhoff disease but gliosis and neuronal loss were less pronounced. Electron microscopic study revealed numerous membranous cytoplasmic bodies (MCB) and zebra bodies in neurons. In addition, varieties of large intracytoplasmic inclusions in astrocytes, a feature distinctly different from classical Tay-Sachs disease, were observed. Numerous cytoplasmic inclusions were also present in oligodendroglia, pericytes and microglial cells.
Similar articles
-
AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.Neurology. 1986 Mar;36(3):438-40. doi: 10.1212/wnl.36.3.438. Neurology. 1986. PMID: 3081832
-
[The so-called amaurotic idiocies. Clinical, morphological and biochemical findings as a basis for modern classification].Veroff Pathol. 1975;96:1-89. Veroff Pathol. 1975. PMID: 180723 German.
-
Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship.Arch Neurol. 1976 Feb;33(2):120-30. doi: 10.1001/archneur.1976.00500020048008. Arch Neurol. 1976. PMID: 175770
-
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.Pediatrics. 2006 Nov;118(5):e1550-62. doi: 10.1542/peds.2006-0588. Epub 2006 Oct 2. Pediatrics. 2006. PMID: 17015493 Free PMC article. Review.
-
The gangliosidoses.Hum Pathol. 1975 Sep;6(5):555-69. doi: 10.1016/s0046-8177(75)80041-4. Hum Pathol. 1975. PMID: 170187 Review.
Cited by
-
Biochemistry and genetics of gangliosidoses.Hum Genet. 1979;50(2):107-43. doi: 10.1007/BF00390234. Hum Genet. 1979. PMID: 116955 Review.
-
The AB-variant of GM2-gangliosidosis. Clinical, biochemical, and pathological studies of two patients.Acta Neuropathol. 1980;52(3):189-202. doi: 10.1007/BF00705807. Acta Neuropathol. 1980. PMID: 6255724
-
Genetics and Therapies for GM2 Gangliosidosis.Curr Gene Ther. 2018;18(2):68-89. doi: 10.2174/1566523218666180404162622. Curr Gene Ther. 2018. PMID: 29618308 Free PMC article. Review.
-
Progress in investigations of sphingolipidoses.Acta Neuropathol. 1978 Aug 7;43(1-2):1-18. doi: 10.1007/BF00684994. Acta Neuropathol. 1978. PMID: 97916 Review. No abstract available.
-
The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.Neurosci Lett. 2021 Nov 1;764:136195. doi: 10.1016/j.neulet.2021.136195. Epub 2021 Aug 25. Neurosci Lett. 2021. PMID: 34450229 Free PMC article. No abstract available.